drugset / Trial / NCT04226274
A Study of the Safety of REN001 in Patients With McArdle Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess REN001 safety in subjects with McArdle Disease
Timeline
- Start
- 2019-12-10
- Primary completion
- 2021-10-11
- Completion
- 2021-10-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mavodelpar | Small molecule | — | Oral |